I thought the power point was the skeleton and Dr. Faro's presentation filled in the bones.
The N-Assay presents a huge issue to the established players (establishment) in the current IVD market space particularly because it is even more disruptive than the BNP!! Results in 30-minutes that identify viable bacteria followed by an overnight incubation period to determine antibiotic sensitivity....WOW! Dr. Faro explained how long it takes to get similar results using current methods. He also pointed out how CHEAP and SIMPLE this 30-min test is. The establishment is right to be worried that the N-Assay will ruin all their efforts and significant capital investments.
Seems like many investors are disappointed that there were seemingly few people that attended Dr. Faro's presentation. Their perceived low attendance reinforces their reasoning for why the share price and trading volume is so low; they see it as a reflection of the lack of interest.
They choose to ignore the fact that there has been an attack on the company by various groups, likely including those who have the most to lose when Nanologix's products are adopted by the market and more importantly, regulatory agencies such as the EPA, DOD, CDC, etc. Once those groups endorse the N-Assay, all laboratories will face tremendous pressure to follow suit.
The comfortable and easy excuse these bothered investors choose to believe is that the company is failing in its effort to expand its market reach. They see the share price as a reflection of this failure. Some have said that the answer is to hire many more sales people. Others have said that Nanologix should team up with a larger company, either by selling to them or licensing the IP. These are obvious and simple solutions, but are for people who either have no idea how businesses work or those who don't know to dig deeper into the details. For example: the company should hire a large sales force using what money? Do you think anyone offering to buy Nanologix is under any real pressure to offer fair value? How does licensing the Flatpack to competitors increase pressure on them to make an offer let alone incentivise them to offer fair value?
Nanologix has been and is a pink sheet company. This fact alone will keep the majority of investors from touching its stock. 99% of pink sheet companies are a scam built to fleece shareholders and line the pockets of the management and their partners to whom they sell INCREDIBLY discounted shares and on OUTRAGEOUSLY favorable terms. I have no doubt that this was how Nanologix was operated by prior management and while their 'partners' may have moved on, its obvious that prior management hasn't.
The company, until relatively recently, has had no real recurring revenue. How did it funds its operations? What about those one-time type costs like building the clean room, purchasing production equipment, patent filings, etc.? The only way I can think of is to sell shares either via PIPEs or on the open market. Those looking to line their own pockets without regard to the company's success KNOW this too. Three mindsets of people come to mind:
a) True investors who want to make a return based on the success of the company.
b) Investors who don't care how the company does so long as they get their return.
c) Competitors and jaded enemies who want to see the company fail.
Take some time to consider the motivations of these groups and put it into the context of the current state of affairs with Nanologix's stock.
- Once the decision was made, Group A would simply make the investment.
- Group B, however, would wait for the share price to hit bottom to maximize their potential return; I would go so far to say that some in Group B may actually try to manipulate the share price lower.
- Group C would want the share price as low as possible and would want to create the perception of very little interest to create a feedback loop for their systemic method of manipulation. By doing so, they basically 'starve' the company. Raising any amount of funds requires more shares which are limited by the Available Shares in the company's charter. The sooner a company reaches that limit the better because then they are forced to take on ever more damaging options all resulting in increasing the likelihood of the company's demise or takeover at pennies on the dollar with respect to its true valuation.
The share price, the trading volume, the state of market penetration, the fight between investors and competitors, the loathsome behavior of previous management and staff -- it is what it is. You'll never figure out the motivations behind the people that write what they write and do what they do. We know there are bashers for hire. We know that there is rampant manipulation in the stock market. We know there are morally bankrupt people.
To those who see themselves as being part of Group A: you should focus on what the good Drs. Sebastian and Jonathan Faro are saying about the product that THEY actively developed. You should focus on what it means that Battelle, the EPA, the DOD, and others are endorsing Nanologix's products. You should focus on what the company has been able to achieve given the constraints that they had WITHOUT the dilution that would have occurred if management were corrupt like previous management.
Part of the reason for my long absence from public MB's was because I accepted that it is what it is. I know that the share price has no bearing on what my investment is truly worth and I know that it is only a matter of time before it is realized.
Dr. Faro's presentation was wonderful. If you don't think so, watch it again and pay close attention. Find out who amongst your friends are knowledgeable or know someone that is knowledgeable about detection of infectious diseases. Seek them out and implore them to watch the video.
The N-Assay presents a huge issue to the established players (establishment) in the current IVD market space particularly because it is even more disruptive than the BNP!! Results in 30-minutes that identify viable bacteria followed by an overnight incubation period to determine antibiotic sensitivity....WOW! Dr. Faro explained how long it takes to get similar results using current methods. He also pointed out how CHEAP and SIMPLE this 30-min test is. The establishment is right to be worried that the N-Assay will ruin all their efforts and significant capital investments.
Seems like many investors are disappointed that there were seemingly few people that attended Dr. Faro's presentation. Their perceived low attendance reinforces their reasoning for why the share price and trading volume is so low; they see it as a reflection of the lack of interest.
They choose to ignore the fact that there has been an attack on the company by various groups, likely including those who have the most to lose when Nanologix's products are adopted by the market and more importantly, regulatory agencies such as the EPA, DOD, CDC, etc. Once those groups endorse the N-Assay, all laboratories will face tremendous pressure to follow suit.
The comfortable and easy excuse these bothered investors choose to believe is that the company is failing in its effort to expand its market reach. They see the share price as a reflection of this failure. Some have said that the answer is to hire many more sales people. Others have said that Nanologix should team up with a larger company, either by selling to them or licensing the IP. These are obvious and simple solutions, but are for people who either have no idea how businesses work or those who don't know to dig deeper into the details. For example: the company should hire a large sales force using what money? Do you think anyone offering to buy Nanologix is under any real pressure to offer fair value? How does licensing the Flatpack to competitors increase pressure on them to make an offer let alone incentivise them to offer fair value?
Nanologix has been and is a pink sheet company. This fact alone will keep the majority of investors from touching its stock. 99% of pink sheet companies are a scam built to fleece shareholders and line the pockets of the management and their partners to whom they sell INCREDIBLY discounted shares and on OUTRAGEOUSLY favorable terms. I have no doubt that this was how Nanologix was operated by prior management and while their 'partners' may have moved on, its obvious that prior management hasn't.
The company, until relatively recently, has had no real recurring revenue. How did it funds its operations? What about those one-time type costs like building the clean room, purchasing production equipment, patent filings, etc.? The only way I can think of is to sell shares either via PIPEs or on the open market. Those looking to line their own pockets without regard to the company's success KNOW this too. Three mindsets of people come to mind:
a) True investors who want to make a return based on the success of the company.
b) Investors who don't care how the company does so long as they get their return.
c) Competitors and jaded enemies who want to see the company fail.
Take some time to consider the motivations of these groups and put it into the context of the current state of affairs with Nanologix's stock.
- Once the decision was made, Group A would simply make the investment.
- Group B, however, would wait for the share price to hit bottom to maximize their potential return; I would go so far to say that some in Group B may actually try to manipulate the share price lower.
- Group C would want the share price as low as possible and would want to create the perception of very little interest to create a feedback loop for their systemic method of manipulation. By doing so, they basically 'starve' the company. Raising any amount of funds requires more shares which are limited by the Available Shares in the company's charter. The sooner a company reaches that limit the better because then they are forced to take on ever more damaging options all resulting in increasing the likelihood of the company's demise or takeover at pennies on the dollar with respect to its true valuation.
The share price, the trading volume, the state of market penetration, the fight between investors and competitors, the loathsome behavior of previous management and staff -- it is what it is. You'll never figure out the motivations behind the people that write what they write and do what they do. We know there are bashers for hire. We know that there is rampant manipulation in the stock market. We know there are morally bankrupt people.
To those who see themselves as being part of Group A: you should focus on what the good Drs. Sebastian and Jonathan Faro are saying about the product that THEY actively developed. You should focus on what it means that Battelle, the EPA, the DOD, and others are endorsing Nanologix's products. You should focus on what the company has been able to achieve given the constraints that they had WITHOUT the dilution that would have occurred if management were corrupt like previous management.
Part of the reason for my long absence from public MB's was because I accepted that it is what it is. I know that the share price has no bearing on what my investment is truly worth and I know that it is only a matter of time before it is realized.
Dr. Faro's presentation was wonderful. If you don't think so, watch it again and pay close attention. Find out who amongst your friends are knowledgeable or know someone that is knowledgeable about detection of infectious diseases. Seek them out and implore them to watch the video.
